Intelligent Bio Solutions Statistics
Total Valuation
INBS has a market cap or net worth of $6.39 million. The enterprise value is $4.21 million.
| Market Cap | 6.39M |
| Enterprise Value | 4.21M |
Important Dates
The last earnings date was Wednesday, August 19, 2026, before market open.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INBS has 2.39 million shares outstanding. The number of shares has increased by 179.27% in one year.
| Current Share Class | 2.39M |
| Shares Outstanding | 2.39M |
| Shares Change (YoY) | +179.27% |
| Shares Change (QoQ) | +56.86% |
| Owned by Insiders (%) | 3.78% |
| Owned by Institutions (%) | 2.94% |
| Float | 2.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.52 |
| Forward PS | 1.15 |
| PB Ratio | 1.41 |
| P/TBV Ratio | 2.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.44 |
| Quick Ratio | 1.15 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,146.57 |
Financial Efficiency
Return on equity (ROE) is -307.69% and return on invested capital (ROIC) is -150.77%.
| Return on Equity (ROE) | -307.69% |
| Return on Assets (ROA) | -76.20% |
| Return on Invested Capital (ROIC) | -150.77% |
| Return on Capital Employed (ROCE) | -175.53% |
| Weighted Average Cost of Capital (WACC) | 21.43% |
| Revenue Per Employee | $76,640 |
| Profits Per Employee | -$226,018 |
| Employee Count | 55 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 4.11 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.20% in the last 52 weeks. The beta is 4.21, so INBS's price volatility has been higher than the market average.
| Beta (5Y) | 4.21 |
| 52-Week Price Change | -82.20% |
| 50-Day Moving Average | 2.19 |
| 200-Day Moving Average | 4.74 |
| Relative Strength Index (RSI) | 57.03 |
| Average Volume (20 Days) | 101,255 |
Short Selling Information
The latest short interest is 49,375, so 2.06% of the outstanding shares have been sold short.
| Short Interest | 49,375 |
| Short Previous Month | 103,339 |
| Short % of Shares Out | 2.06% |
| Short % of Float | 2.29% |
| Short Ratio (days to cover) | 0.61 |
Income Statement
In the last 12 months, INBS had revenue of $4.22 million and -$12.43 million in losses. Loss per share was -$8.44.
| Revenue | 4.22M |
| Gross Profit | 2.05M |
| Operating Income | -12.31M |
| Pretax Income | -12.47M |
| Net Income | -12.43M |
| EBITDA | -11.15M |
| EBIT | -12.31M |
| Loss Per Share | -$8.44 |
Balance Sheet
The company has $3.99 million in cash and $1.82 million in debt, with a net cash position of $2.17 million or $0.91 per share.
| Cash & Cash Equivalents | 3.99M |
| Total Debt | 1.82M |
| Net Cash | 2.17M |
| Net Cash Per Share | $0.91 |
| Equity (Book Value) | 5.29M |
| Book Value Per Share | 1.90 |
| Working Capital | 2.17M |
Cash Flow
In the last 12 months, operating cash flow was -$11.93 million and capital expenditures -$125,731, giving a free cash flow of -$12.05 million.
| Operating Cash Flow | -11.93M |
| Capital Expenditures | -125,731 |
| Depreciation & Amortization | 1.16M |
| Net Borrowing | n/a |
| Free Cash Flow | -12.05M |
| FCF Per Share | -$5.04 |
Margins
Gross margin is 48.63%, with operating and profit margins of -292.03% and -294.91%.
| Gross Margin | 48.63% |
| Operating Margin | -292.03% |
| Pretax Margin | -295.80% |
| Profit Margin | -294.91% |
| EBITDA Margin | -264.42% |
| EBIT Margin | -292.03% |
| FCF Margin | n/a |
Dividends & Yields
INBS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -179.27% |
| Shareholder Yield | -179.27% |
| Earnings Yield | -194.65% |
| FCF Yield | -188.73% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 42.43% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 16, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Dec 16, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |